SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Longevity Biotech Stocks Rise Amid 27 Trillion Healthcare Shift Toward Cell Restoration SpaceX and OpenAI IPOs Could Surpass Berkshire Hathaway on Debut Day Prediction Markets Suggest Market Expert Raja Venkatramans Stock Picks for May 27 Draw Attention US Funds Build Cash Reserves Ahead of Anticipated SpaceX and OpenAI Public Listings Trump Administration Proposal Mandates Offshore Green Card Applications Raising Business Concerns Coursera Q1 2026 Earnings EPS Miss Sends Mixed Signal as Stock Gains GLIBK Q1 2026 Earnings Significant EPS Miss Sends Stock Lower NOTV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Stock Yards Bancorp SYBT Q1 2026 Earnings Earnings Beat Estimates Amid Solid Performance Oscar Health Inc OSCR Q1 2026 Earnings Massive EPS Beat Signals Strong Underwriting RCKY Q1 2026 Earnings EPS Misses Expectations as Revenue Details Remain Undisclosed LightInTheBox LITB Surges 48 Testing Key Resistance at 275 as Volume Picks Up Allspring Income Opportunities Fund EAD Edges Higher on Modest Gains Drugs Made In America Acquisition II Corp Unit DMIIU Holds Steady Near Trust Value Amid Low Volatility Cellectar Biosciences CLRB Edges Higher Support Levels Tested as Biotech Sector Shows Mixed Signals Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher American Shared Hospital Services AMS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges SKIN Q1 2026 Earnings EPS Beats Estimates Amid NarrowerThanExpected Loss CUK Q1 2026 Earnings EPS Misses Estimate but Stock Rallies on Operational Momentum SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline RYAAY Q1 2026 Earnings Wide EPS Miss Still Spurs Positive Market Reaction AtHome Care Devices Market Poised for Growth Amid Pediatric Access Challenges CTMX Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues Innovative Solutions and Support Inc ISSC Surges 456 as Momentum Builds Toward Key Resistance Cardiol Therapeutics CRDL Sees Minor Decline Holds Above Key Support JELDWEN Holding JELD Edges Higher Approaching Key Resistance Level Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing Erasca Inc ERAS Slides 315 as Biotech Sector Faces Pressure Key Levels to Watch Formula Systems FORTY Holds Steady at 13905 Amid Consolidation Phase Pimco Municipal Income Fund II PML Holds Steady Amid Interest Rate Uncertainty HCM IV Acquisition Corp Unit HACQU Holds Near Trust Value as SPAC Remains in PreBusiness Combination Phase